Verastem

Verastem Oncology (Verastem, Inc.) is a development-stage biopharmaceutical company focused on developing novel therapies for cancers driven by the RAS/MAPK pathway, including KRAS-mutant tumors. Its work includes the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer, plus a pipeline targeting KRAS G12D inhibition. As a clinical-stage pharmaceutical company it publishes no public developer API, developer portal, or SDKs; this profile was surfaced as a portfolio company of bessemer-venture-partners and enriched with verified identity only.

Verastem is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Oncology.

2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyHealthcareBiotechnologyPharmaceuticalsOncologyLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/verastem: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: verastem
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/verastem.png
name: Verastem
description: Verastem Oncology (Verastem, Inc.) is a development-stage biopharmaceutical company focused on developing novel
  therapies for cancers driven by the RAS/MAPK pathway, including KRAS-mutant tumors. Its work includes the first FDA-approved
  treatment for KRAS-mutant recurrent low-grade serous ovarian cancer, plus a pipeline targeting KRAS G12D inhibition. As
  a clinical-stage pharmaceutical company it publishes no public developer API, developer portal, or SDKs; this profile was
  surfaced as a portfolio company of bessemer-venture-partners and enriched with verified identity only.
url: https://raw.githubusercontent.com/api-evangelist/verastem/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bessemer-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Healthcare
- Biotechnology
- Pharmaceuticals
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.verastem.com/
- type: About
  url: https://www.verastem.com/about/
- type: Pipeline
  url: https://www.verastem.com/our-science/pipeline/
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1